Month: March 2022

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — (TSX: TXT.UN; TXT.PR.A) Top 10 Split Trust (the “Fund”) announces results of operations for the year ended December 31, 2021. Increase in net assets attributable to holders of Capital Units amounted to $2.76 million or $3.81 per Capital Unit. As at December 31, 2021, net assets attributable to holders of Capital Units were $2.54 million or $4.38 per Capital Unit. Interest payments of $0.56 million or $0.78 per Preferred Security and cash distributions to Capital Unit holders totaling $0.18 million or $0.27 per Capital Unit were paid during the year. The Fund’s investment objectives for the Capital Units are (i) to provide holders of Capital Units, upon redemption, with the benefit of any capital appreciation in the market price of the securities in the Financial Portfolio and (ii) to pay...

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — (TSX: SBN; SBN.PR.A) S Split Corp. (the “Fund”) announces results of operations for the year ended December 31, 2021. Increase in net assets attributable to holders of Class A shares amounted to $2.65 million or $3.30 per Class A share. As at December 31, 2021, net assets attributable to holders of Class A shares were $4.34 million or $8.53 per Class A share. Cash distributions to Preferred shareholders totaling $0.42 million or $0.53 per Preferred share and to Class A shareholders totaling $0.16 million of $0.21 per Class A share were paid during the year.   The investment objectives for the Class A shares are: (i) to provide holders of Class A shares with monthly cash distributions targeted to be 6.00% per annum on the net asset value (“NAV”) of the Class A shares; and (ii) to provide...

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — (TSX: WFS; WFS.PR.A) World Financial Split Corp. (the “Fund”) announces results of operations for the year ended December 31, 2021. Increase in net assets attributable to holders of Class A shares amounted to $1.86 million or $1.91 per Class A share.   As at December 31, 2021, net assets attributable to holders of Class A shares were $3.19 million or $3.43 per Class A share. Cash distributions to Preferred Shareholders totaling $0.51 million or $0.53 per Preferred share were paid during the year. The Fund is a mutual fund corporation which invests in a portfolio that includes common equity securities selected from the ten largest financial services or real estate companies by market capitalization in each of Canada, the United States and the Rest of the World (the “Portfolio Universe”)....

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) — Mulvihill Premium Yield Fund (the “Fund”) announces results of operations for the year ended December 31, 2021. Increase in net assets attributable to holders of Class I amounted to $1.56 million or $1.33 per Class I unit, increase in net assets attributable to holders of Class F units amounted to $0.95 million or $1.27 per Class F unit and increase in net assets attributable to holders of Class A units amounted to $0.57 million or $0.74 per Class A unit. As at December 31, 2021, net assets attributable to holders of Class I were $14.72 million or $11.34 per Class I unit; net assets attributable to holders of Class F were $9.92 million or $11.33 per Class F unit and net assets attributable to holders of Class A units were $15.64 million or $11.01 per Class A unit. Distributions paid to...

MALVERN, Pa., March 21, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2021. Recent HighlightsReported revenue of $8.4 million for the fourth quarter and $29.5 million for the full year 2021, representing growth of 48% and 62%, respectively, over the corresponding periods of 2020 Announced publication of 12-month results from the BRAVO Study with continued positive outcomes through 24 months Entered into an exclusive distribution agreement with Next Science to market its proprietary SiteGuard...

HORSHAM, Pa., March 21, 2022 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the fourth quarter and full year ended December 31, 2021. Recent HighlightsRevenue in the fourth quarter of 2021 was a record $9.1 million, an increase of 35% over the fourth quarter of 2020Global recurring revenue was $6.7 million, a 32% increase over the fourth quarter of 2020 Gross domestic recurring billings were $6.1 million, a 14% increase over the fourth quarter 2020 (See Reconciliation of Non-GAAP measures below)Revenue for the full year 2021 was $30.0 million, a 30% increase over the full year 2020Global recurring revenue was $22.5 million,...

Announces decision to discontinue development of ORIC-101 Company will focus on advancing its three single agent Phase 1 programs, ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers, and ORIC-944 in prostate cancer, with initial data expected from the three programs in 1H 2023 With cash and investments of $280.4 million, cash runway extended into 2H 2024 Conference call and webcast today at 5:00 p.m. ET SOUTH SAN FRANCISCO Calif. and SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the discontinuation of ORIC-101 and also reported financial results and operational updates for the quarter and year ended December 31, 2021. The company conducted planned...